Skip To Content
bool(false)

Translating Discoveries Into Treatments: What Can Patients Do?

How can we translate scientific discoveries into new treatments? In Canada, we are fortunate that top thinkers across the country are working on this question. The answer requires contributions from research scientists and medical…

Are Clinical Trials Safe for Children?

Does your child have an inherited eye disease? If you had the chance, would you enrol her or him in a clinical trial that was testing a new gene therapy or stem…

Three-year FBC Grant Ends With New Discovery

Turning research into treatments takes a long time. Some studies have estimated that approximately 14% of new discoveries make it into the clinic, and that this journey from the laboratory into the…

One Year Results of Choroideremia Gene Therapy Trial

In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…

First Gene Therapy Results for Choroideremia Suggest Cautious Optimism

The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…

Ocular Gene Therapy Centre Established at U of A

A $5 million grant from Alberta’s provincial health funder is establishing a Canadian Centre of Excellence for ocular gene therapy research. Drs. Ian MacDonald and Tania Bubela at the University of Alberta…

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy